Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
Tabernero, Josep, Hoff, Paulo M, Shen, Lin, Ohtsu, Atsushi, Shah, Manish A, Cheng, Karen, Song, Chunyan, Wu, Haiyan, Eng-Wong, Jennifer, Kim, Katherine, Kang, Yoon-Koo
Published in The lancet oncology (01.10.2018)
Published in The lancet oncology (01.10.2018)
Get full text
Journal Article
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
El-Khoueiry, Anthony B, Dr, Sangro, Bruno, MD, Yau, Thomas, MD, Crocenzi, Todd S, MD, Kudo, Masatoshi, MD, Hsu, Chiun, MD, Kim, Tae-You, MD, Choo, Su-Pin, BMBS, Trojan, Jörg, MD, Welling, Theodore H, MD, Meyer, Tim, MD, Kang, Yoon-Koo, MD, Yeo, Winnie, MD, Chopra, Akhil, MD, Anderson, Jeffrey, MD, dela Cruz, Christine, MD, Lang, Lixin, PhD, Neely, Jaclyn, PhD, Tang, Hao, PhD, Dastani, Homa B, PhD, Melero, Ignacio
Published in The Lancet (British edition) (24.06.2017)
Published in The Lancet (British edition) (24.06.2017)
Get full text
Journal Article
Gastrointestinal stromal tumours
Blay, Jean-Yves, Kang, Yoon-Koo, Nishida, Toshiroo, von Mehren, Margaret
Published in Nature reviews. Disease primers (18.03.2021)
Published in Nature reviews. Disease primers (18.03.2021)
Get full text
Journal Article
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Zhu, Andrew X, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Galle, Peter R, Llovet, Josep M, Assenat, Eric, Brandi, Giovanni, Pracht, Marc, Lim, Ho Yeong, Rau, Kun-Ming, Motomura, Kenta, Ohno, Izumi, Merle, Philippe, Daniele, Bruno, Shin, Dong Bok, Gerken, Guido, Borg, Christophe, Hiriart, Jean-Baptiste, Okusaka, Takuji, Morimoto, Manabu, Hsu, Yanzhi, Abada, Paolo B, Kudo, Masatoshi
Published in The lancet oncology (01.02.2019)
Published in The lancet oncology (01.02.2019)
Get full text
Journal Article
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Kang, Yoon-Koo, Chen, Li-Tzong, Ryu, Min-Hee, Oh, Do-Youn, Oh, Sang Cheul, Chung, Hyun Cheol, Lee, Keun-Wook, Omori, Takeshi, Shitara, Kohei, Sakuramoto, Shinichi, Chung, Ik-Joo, Yamaguchi, Kensei, Kato, Ken, Sym, Sun Jin, Kadowaki, Shigenori, Tsuji, Kunihiro, Chen, Jen-Shi, Bai, Li-Yuan, Oh, Sung-Yong, Choda, Yasuhiro, Yasui, Hisateru, Takeuchi, Kentaro, Hirashima, Yoshinori, Hagihara, Shunsuke, Boku, Narikazu
Published in The lancet oncology (01.02.2022)
Published in The lancet oncology (01.02.2022)
Get full text
Journal Article
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Thuss-Patience, Peter C, MD, Shah, Manish A, MD, Ohtsu, Atsushi, MD, Van Cutsem, Eric, Prof, Ajani, Jaffer A, Prof, Castro, Hugo, MD, Mansoor, Wasat, PhD, Chung, Hyun Cheol, Prof, Bodoky, Gyorgy, Prof, Shitara, Kohei, MD, Phillips, Gail D Lewis, MS, van der Horst, Tina, MSc, Harle-Yge, Marie-Laurence, MSc, Althaus, Betsy L, PharmD, Kang, Yoon-Koo, Prof
Published in The lancet oncology (01.05.2017)
Published in The lancet oncology (01.05.2017)
Get full text
Journal Article
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Hong, David S, Kang, Yoon-Koo, Borad, Mitesh, Sachdev, Jasgit, Ejadi, Samuel, Lim, Ho Yeong, Brenner, Andrew J, Park, Keunchil, Lee, Jae-Lyun, Kim, Tae-You, Shin, Sangjoon, Becerra, Carlos R, Falchook, Gerald, Stoudemire, Jay, Martin, Desiree, Kelnar, Kevin, Peltier, Heidi, Bonato, Vinicius, Bader, Andreas G, Smith, Susan, Kim, Sinil, O'Neill, Vincent, Beg, Muhammad S
Published in British journal of cancer (01.05.2020)
Published in British journal of cancer (01.05.2020)
Get full text
Journal Article
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Kang, Yoon-Koo, Boku, Narikazu, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Chen, Li-Tzong
Published in The Lancet (British edition) (02.12.2017)
Published in The Lancet (British edition) (02.12.2017)
Get full text
Journal Article
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Nishida, Toshirou, Blay, Jean-Yves, Hirota, Seiichi, Kitagawa, Yuko, Kang, Yoon-Koo
Published in Gastric Cancer (01.01.2016)
Published in Gastric Cancer (01.01.2016)
Get full text
Journal Article
Book Review
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
Chen, Li-Tzong, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Sameshima, Hiroki, Kang, Yoon-Koo, Boku, Narikazu
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2020)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2020)
Get full text
Journal Article
Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)
Seo, Seyoung, Ryu, Min-Hee, Park, Young Soo, Ahn, Ji Yong, Park, Yangsoon, Park, Sook Ryun, Ryoo, Baek-Yeol, Lee, Gin Hyug, Jung, Hwoon-Young, Kang, Yoon-Koo
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2019)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2019)
Get full text
Journal Article
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Wagner, Anna Dorothea, Grabsch, Heike I, Mauer, Murielle, Marreaud, Sandrine, Caballero, Carmela, Thuss-Patience, Peter, Mueller, Lothar, Elme, Annelie, Moehler, Markus Hermann, Martens, Uwe, Kang, Yoon-Koo, Rha, Sun Young, Cats, Annemieke, Tokunaga, Masanori, Lordick, Florian
Published in BMC cancer (24.05.2019)
Published in BMC cancer (24.05.2019)
Get full text
Journal Article
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Heinrich, Michael C, Jones, Robin L, von Mehren, Margaret, Schöffski, Patrick, Serrano, César, Kang, Yoon-Koo, Cassier, Philippe A, Mir, Olivier, Eskens, Ferry, Tap, William D, Rutkowski, Piotr, Chawla, Sant P, Trent, Jonathan, Tugnait, Meera, Evans, Erica K, Lauz, Tamieka, Zhou, Teresa, Roche, Maria, Wolf, Beni B, Bauer, Sebastian, George, Suzanne
Published in The lancet oncology (01.07.2020)
Published in The lancet oncology (01.07.2020)
Get full text
Journal Article
Management of gastric cancer in Asia: resource-stratified guidelines
Shen, Lin, Prof, Shan, Yan-Shen, Prof, Hu, Huang-Ming, MD, Price, Timothy J, Prof, Sirohi, Bhawna, DCH, Yeh, Kun-Huei, Prof, Yang, Yi-Hsin, PhD, Sano, Takeshi, MD, Yang, Han-Kwang, Prof, Zhang, Xiaotian, MD, Park, Sook Ryun, MD, Fujii, Masashi, Prof, Kang, Yoon-Koo, Prof, Chen, Li-Tzong, Prof
Published in The lancet oncology (01.11.2013)
Published in The lancet oncology (01.11.2013)
Get full text
Journal Article
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
OHTSU, Atsushi, SHAH, Manish A, STARNAWSKI, Michal, KANG, Yoon-Koo, VAN CUTSEM, Eric, SUN YOUNG RHA, SAWAKI, Akira, SOOK RYUN PARK, HO YEONG LIM, YAMADA, Yasuhide, JIAN WU, LANGER, Bernd
Published in Journal of clinical oncology (20.10.2011)
Published in Journal of clinical oncology (20.10.2011)
Get full text
Journal Article
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
Wainberg, Zev A, Enzinger, Peter C, Kang, Yoon-Koo, Qin, Shukui, Yamaguchi, Kensei, Kim, In-Ho, Saeed, Anwaar, Oh, Sang Cheul, Li, Jin, Turk, Haci Mehmet, Teixeira, Alexandra, Borg, Christophe, Hitre, Erika, Udrea, Adrian A, Cardellino, Giovanni Gerardo, Sanchez, Raquel Guardeño, Collins, Helen, Mitra, Siddhartha, Yang, Yingsi, Catenacci, Daniel V T, Lee, Keun-Wook
Published in The lancet oncology (01.11.2022)
Published in The lancet oncology (01.11.2022)
Get full text
Journal Article
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Yau, Thomas, Hsu, Chiun, Kim, Tae-You, Choo, Su-Pin, Kang, Yoon-Koo, Hou, Ming-Mo, Numata, Kazushi, Yeo, Winnie, Chopra, Akhil, Ikeda, Masafumi, Kuromatsu, Ryoko, Moriguchi, Michihisa, Chao, Yee, Zhao, Huanyu, Anderson, Jeffrey, Cruz, Christine Dela, Kudo, Masatoshi
Published in Journal of hepatology (01.09.2019)
Published in Journal of hepatology (01.09.2019)
Get full text
Journal Article
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
Meric-Bernstam, Funda, Beeram, Muralidhar, Hamilton, Erika, Oh, Do-Youn, Hanna, Diana L, Kang, Yoon-Koo, Elimova, Elena, Chaves, Jorge, Goodwin, Rachel, Lee, Jeeyun, Nabell, Lisle, Rha, Sun Young, Mayordomo, Jose, El-Khoueiry, Anthony, Pant, Shubham, Raghav, Kanwal, Kim, Jin Won, Patnaik, Amita, Gray, Todd, Davies, Rupert, Ozog, Mark A, Woolery, Joseph, Lee, Keun-Wook
Published in The lancet oncology (01.12.2022)
Published in The lancet oncology (01.12.2022)
Get full text
Journal Article
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
CHENG, Ann-Lii, KANG, Yoon-Koo, OMATA, Masao, LOWENTHAL, Susan Pitman, LANZALONE, Silvana, LIQIANG YANG, JOSE LECHUGA, Maria, RAYMOND, Eric, LIN, Deng-Yn, PARK, Joong-Won, KUDO, Masatoshi, SHUKUI QIN, CHUNG, Hyun-Cheol, XIANGQUN SONG, JIANMINGXU, POGGI, Guido
Published in Journal of clinical oncology (10.11.2013)
Published in Journal of clinical oncology (10.11.2013)
Get full text
Journal Article
Conference Proceeding